Please provide your email address to receive an email when new articles are posted on . During 4.7 years, 360 patients had 488 serious adverse reactions. More than 27% of serious reactions were ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...

The U.S. Food and Drug Administration on Friday approved the first drug to treat people with potentially deadly food allergies. Xolair, an injection, is now available to adults and children 1 year and ...

Fixed drug eruptions (FDEs) represent a distinctive subset of adverse drug reactions, characterised by the recurrence of lesions at identical anatomical sites with each exposure to the causative ...

Drug-induced photosensitivity reactions represent a complex group of cutaneous adverse events that occur when certain medications interact with ultraviolet or visible light. These reactions are ...

The FDA approved the drug Xolair earlier this month, making it the first medication approved to reduce allergic reactions after accidental exposures. A new study published in the New England Journal ...

A close up of salted peanuts in a white bowl next to allergy medication on a white top. Senior Correspondent About 20 million people in the U.S.—including four million children—have food allergies.

An injectable drug used for decades to treat asthma substantially reduced potentially life-threatening reactions in children with an allergy who were exposed to trace amounts of peanuts, eggs, milk ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment. Anaphylaxis symptoms can appear within an hour of injection and may lead to severe ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

A new study published in the New England Journal of Medicine shows just how effective an old asthma drug can be in preventing allergic reactions in people with food allergies. NPR's Allison Aubrey ...